Back to top

Halozyme reports Q2 non-GAAP EPS $2.28, consensus $1.82

Reports Q2 revenue $481M, consensus $402.28M. “We delivered another quarter of strong performance, with multiple proof points demonstrating the att...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Halozyme Therapeutics, Inc. (HALO)